Literature DB >> 6833213

The primary structure of human serum transferrin. The structures of seven cyanogen bromide fragments and the assembly of the complete structure.

R T MacGillivray, E Mendez, J G Shewale, S K Sinha, J Lineback-Zins, K Brew.   

Abstract

The amino acid sequences of seven cyanogen bromide fragments of human serum transferrin have been determined, and the primary structure of transferrin established by determining the order of these and three additional fragments (Sutton, M. R., MacGillivray, R. T. A., and Brew, K. (1975) Eur. J. Biochem. 51, 43-48) in the polypeptide chain. The order of the fragments was deduced from peptides that overlap methionyl residues which were obtained by thermolysin digestion of performic acid-oxidized transferrin or by partial peptic hydrolysis of unmodified transferrin, together with other evidence. The polypeptide chain of transferrin contains 679 amino acid residues, which together with the two N-linked oligosaccharide chains gives a calculated molecular weight of 79,570. Transferrin consists of two homologous domains (residues 1-336, 337-679), each associated with a single Fe-binding site, with both sites of glycosylation in the carboxyl-terminal domain at positions 413 and 611. Consideration of the primary structure in relation to previously published results provides information concerning the evolutionary development of transferrins and related proteins, and the locations of metal-binding residues in the transferrin molecule.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6833213

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Characterization of Transferrin Glycopeptide Structures in Human Cerebrospinal Fluid.

Authors:  Kristy J Brown; Adeline Vanderver; Eric P Hoffman; Raphael Schiffmann; Yetrib Hathout
Journal:  Int J Mass Spectrom       Date:  2012-02-15       Impact factor: 1.986

Review 2.  Bacterial transferrin receptors--structure, function and contribution to virulence.

Authors:  P Williams; E Griffiths
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

3.  Comparative binding study of aluminum and chromium to human transferrin. Effect of iron.

Authors:  A A Moshtaghie; M Ani; M R Bazrafshan
Journal:  Biol Trace Elem Res       Date:  1992 Jan-Mar       Impact factor: 3.738

4.  The nucleotide sequence of Xenopus laevis transferrin mRNA.

Authors:  J E Moskaitis; R L Pastori; D R Schoenberg
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

5.  cDNA and protein sequence of bovine lactoferrin.

Authors:  P E Mead; J W Tweedie
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

6.  Expression, purification, and characterization of recombinant human transferrin from rice (Oryza sativa L.).

Authors:  Deshui Zhang; Somen Nandi; Paula Bryan; Steve Pettit; Diane Nguyen; Mary Ann Santos; Ning Huang
Journal:  Protein Expr Purif       Date:  2010-05-04       Impact factor: 1.650

7.  Transferrin-mediated targeting of bacteriophage HK97 nanoparticles into tumor cells.

Authors:  Rick K Huang; Nicole F Steinmetz; Chi-Yu Fu; Marianne Manchester; John E Johnson
Journal:  Nanomedicine (Lond)       Date:  2011-01       Impact factor: 5.307

8.  Inhibition of the specific binding of human lactotransferrin to human peripheral-blood phytohaemagglutinin-stimulated lymphocytes by fluorescein labelling and location of the binding site.

Authors:  D Legrand; J Mazurier; P Maes; E Rochard; J Montreuil; G Spik
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

9.  High Accuracy Molecular Weight Determination and Variation Characterization of Proteins Up To 80 ku by Ionspray Mass Spectrometry.

Authors:  R Feng; Y Konishi; A W Bell
Journal:  J Am Soc Mass Spectrom       Date:  1991-09       Impact factor: 3.109

10.  Transferrin-receptor interaction and iron uptake by reticulocytes of vertebrate animals--a comparative study.

Authors:  B C Lim; H J McArdle; E H Morgan
Journal:  J Comp Physiol B       Date:  1987       Impact factor: 2.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.